Clinical Trials Logo

Clinical Trial Summary

Medical termination of pregnancy is a common and safe alternative to surgical termination of pregnancy(8). The current protocol in the investigators unit includes oral administration of Mifepristone 600 mg and oral Misoprostol 400 mcg in a time interval of 48 hours. There is little data to compare the efficacy of concomitant administration of both drugs and different time intervals. This study evaluates the success rate and side effects of medical termination of pregnancy while both drugs are administrated concomitantly in comparison to interval of 48 hours between the drugs.


Clinical Trial Description

Medical termination of pregnancy is a common and safe alternative to surgical termination of pregnancy(8). According to the original protocol ,the administration of oral Mifepristone 600 mg is followed by oral Misoprostol 400 mcg in an interval of 36 to 48 hours. Shortening this time interval may convince patients to avoid surgical termination of pregnancy, enhance patient's compliance to treatment and even be more economically. The current protocol in the investigators unit includes oral administration of Mifepristone 600 mg and oral Misoprostol 400 mcg in a time interval of 48 hours. The patients are recommended to have an ultrasound examination after 2 to 3 weeks. There is little data to compare the efficacy of concomitant administration of both drugs according to the dosage of this protocol and different time intervals. This study evaluates the success rate and side effects of medical termination of pregnancy while both drugs are administrated concomitantly in comparison to interval of 48 hours between the drugs. Participants in the study group will be given both drugs at the same time while participants in the control group will be given Mifepristone and Misoprostol in an interval of 48 hours. The investigators hypothesis is that administration of both drugs concomitantly will not change significantly the success rate of the procedure and will not enhance the side effects. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03440866
Study type Interventional
Source HaEmek Medical Center, Israel
Contact
Status Active, not recruiting
Phase N/A
Start date March 1, 2018
Completion date December 30, 2023

See also
  Status Clinical Trial Phase
Not yet recruiting NCT01639989 - Doppler Assesment of Blood Flow in the Spiral Arteries N/A
Recruiting NCT06002412 - Quality Control of Ultrasound Images During Early Pregnancy Via AI
Completed NCT03258385 - Vitamin B12 Supplementation to Improve B12 Status and Child Development N/A
Completed NCT04152278 - Chlamydia Tracomatis and Other Lower Genital Tract Infections Among Women With Unexplained Early Miscarriage
Completed NCT03161873 - Cycle and Pregnancy Monitoring With Wearable Sensor Technology (AVA)
Completed NCT02979834 - When Will I Feel The First Movements of My Baby? N/A
Terminated NCT02847910 - ClinicaI Observation of Induced Abortion With Disposable Tissue Suction Tube N/A
Completed NCT04371991 - Kisspeptin Levels in Early Pregnancy
Active, not recruiting NCT05142020 - Biomarkers for Early Screening of Gestational Diabetes Mellitus
Recruiting NCT04717661 - A Diagnostic Test Study of Characteristic Sound Waves in Radial Artery of Early Pregnant Women
Completed NCT05484869 - Very Advanced Maternal Aged Pregnants and Early Adolescent Pregnant Women
Recruiting NCT04738370 - Assessment of Biomarkers in Pregnancy on Unknown Location and Ectopic Pregnancy
Completed NCT06228118 - Clinical Trail of the Lay User Study and Method Comparison Study of Human Chorionic Gonadotropin (HCG) Test System
Completed NCT06228131 - Detection of hCG in Early Pregnancy Clinical Samples
Active, not recruiting NCT04388605 - Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic
Completed NCT00340782 - Influence of Social and Environmental Factors on Women's Reproductive Function in a Maya Community of Guatemala N/A